Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action
Conditions
- Insulin Sensitivity
- Multiple Mitochondrial Dysfunctions Syndrome
Interventions
- DRUG: Dapagliflozin
- DRUG: Placebo
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators